Key result
Endothelial cell-derived extracellular vesicles serve as emerging biomarkers for the diagnosis, risk stratification, and prognostication of patients with atherosclerosis.
Key points are not available for this paper at this time.
Should not yet inform clinical decisions in atherosclerosis; leaves open validation of endothelial EVs in prospective cohorts.
Vessel Plus is an open acccess journal, which publishes articles related to vascular diseases, including acute respiratory distress syndrome, aneurysm, atherosclerosis, hypertension, stroke, peripheral vascular or pulmonary vascular diseases, etc.
No takes yet. Share an insight, caveat, or question.
Berezin et al. (2020) studied this question. Endothelial cell-derived extracellular vesicles serve as emerging biomarkers for the diagnosis, risk stratification, and prognostication of patients with atherosclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: